BioAtla (BCAB) Current Assets (2020 - 2026)

BioAtla's Current Assets history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• On a quarterly basis, Current Assets fell 91.76% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a 91.76% decrease from a year earlier, with the FY2025 full-year figure at $8.0 million, down 84.36% from the prior year.
• Current Assets fell to $3.1 million in Q1 2026 per BCAB's latest filing, from $8.0 million in the prior quarter.
• Across five years, Current Assets topped out at $224.0 million in Q1 2022 and bottomed at $3.1 million in Q1 2026.
• The 5-year median for Current Assets is $86.4 million (2024), against an average of $106.9 million.
• Across the five-year window, Current Assets retreated 0.25% in 2022 and tumbled 91.76% in 2026, its largest moves.
• Year by year, Current Assets stood at $220.4 million in 2022, then plunged by 47.19% to $116.4 million in 2023, then sank by 55.99% to $51.2 million in 2024, then tumbled by 84.36% to $8.0 million in 2025, then sank by 61.4% to $3.1 million in 2026.
• Per Business Quant, the three latest BCAB Current Assets figures stand at $3.1 million (Q1 2026), $8.0 million (Q4 2025), and $9.7 million (Q3 2025).